Industrial and Commercial Bank of China Limited (1398.HK) vs Johnson & Johnson (JNJ)

Industrial and Commercial Bank of China Limited is one of China’s largest state-controlled commercial banks. It provides corporate banking, personal banking, wealth management, payments, and treasury services through a broad domestic and international network. The bank serves major companies, public-sector entities, small businesses, and retail customers. Its results are influenced by Chinese credit growth, interest-rate spreads, asset quality, government policy, and the health of the country’s property, infrastructure, and industrial sectors.

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.